Ponatinib given for advanced leukemia relapse after allo-SCT

Bone Marrow Transplant. 2015 Apr;50(4):599-600. doi: 10.1038/bmt.2014.301. Epub 2015 Jan 12.

Authors

K Hirschbuehl¹, A Rank¹, T Pfeiffer¹, H R Slawik², G Schlimok¹, H J Kolb³, Ch Schmid¹

Affiliations

¹ Department of Hematology and Oncology, Klinikum Augsburg, Augsburg, Germany.
² Onkologische Schwerpunktpraxis Augsburg, Augsburg, Germany.
³ Department of Hematology and Oncology, Klinikum Rechts der Isar, University of Munich, Munich, Germany.

PMID: 25581405
DOI: 10.1038/bmt.2014.301

No abstract available

Publication types

Letter

MeSH terms

Adult
Allografts
Antineoplastic Agents / administration & dosage*
Female
Humans
Imidazoles / administration & dosage*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
Pyridazines / administration & dosage*
Recurrence
Stem Cell Transplantation*

Substances

Antineoplastic Agents
Imidazoles
Pyridazines
ponatinib